Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BOC-12-ADO-OH, also known as Boc-12-Ado-OH, is a synthetic molecule that serves as a versatile linker in the development of protein degrader molecules, known as proteolysis-targeting chimeras (PROTACs). It features an alkane chain with a terminal carboxylic acid and Boc-protected amino groups, which can be utilized in various chemical reactions to create stable amide bonds and deprotected free amines.

18934-81-1

Post Buying Request

18934-81-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

18934-81-1 Usage

Uses

Used in Pharmaceutical Industry:
BOC-12-ADO-OH is used as a PROTAC linker for the synthesis of protein degraders, which are a novel class of therapeutics designed to selectively target and degrade specific proteins within cells. The terminal carboxylic acid of BOC-12-ADO-OH can react with primary amine groups in the presence of activators, such as EDC or HATU, to form a stable amide bond. This property makes it a valuable component in the development of targeted protein degradation therapies.
Additionally, the Boc group in BOC-12-ADO-OH can be deprotected under mild acidic conditions, allowing for the formation of free amines. This feature further enhances the molecule's utility in the synthesis of various biologically active compounds and drug candidates.

Check Digit Verification of cas no

The CAS Registry Mumber 18934-81-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,9,3 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 18934-81:
(7*1)+(6*8)+(5*9)+(4*3)+(3*4)+(2*8)+(1*1)=141
141 % 10 = 1
So 18934-81-1 is a valid CAS Registry Number.

18934-81-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (09780)  Boc-12-Ado-OH  ≥98.0% (TLC)

  • 18934-81-1

  • 09780-500MG

  • 1,095.12CNY

  • Detail

18934-81-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 12-[(2-methylpropan-2-yl)oxycarbonylamino]dodecanoic acid

1.2 Other means of identification

Product number -
Other names 12-(t-butoxycarbonyl)amino-dodecanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:18934-81-1 SDS

18934-81-1Relevant articles and documents

Synthetic micelle sensitive to IR light via a two-photon process

Goodwin, Andrew P.,Mynar, Justin L.,Ma, Yingzhong,Fleming, Graham R.,Frechet, Jean M. J.

, p. 9952 - 9953 (2005)

A micellar assembly of molecules constituted of poly(ethylene glycol) as the hydrophilic component and 2-diazo-1,2-naphthoquinone as the hydrophobic component was shown to be destroyed in a two-photon photoreaction triggered by infrared light with release of an encapsulated fluorescent probe molecule. Copyright

Molecular recognition of histidine-tagged molecules by metal-chelating lipids monitored by fluorescence energy transfer and correlation spectroscopy

Dorn, Ingmar T.,Neumaier, Klaus R.,Tampé, Robert

, p. 2753 - 2763 (1998)

Complex binding of proteins by metal-chelating lipids via surface- exposed or protein-engineered histidines provides an universal and powerful concept for the orientation and two-dimensional crystallization of proteins at self-organized interfaces. To dem

Preparation and application of three-branch RGD modified brain glioma targeting lipid material

-

Paragraph 02=021, (2021/11/03)

The invention discloses a three-branch RGD-modified glioma targeting lipid material which is used for targeted delivery of brain glioma treatment drugs. One end of the novel lipid material is connected with cholesterol extending through polyethylene glycol, and the other end of the novel lipid material is connected with RGD peptide with brain glioma targeting function, and the novel lipid material can be used for integrin receptor α which is highly expressed on the surface of brain capillary endothelial cells and brain glioma cells. v β3 The affinity between the brain glioma is achieved through the affinity between the brain glioma, and the effective concentration of the therapeutic drug to the brain tumor is improved. The novel lipid lipid material can be used for liposome. The prepared paclitaxel liposome has obvious brain targeting property and tumor targeting property, and has wide application prospects.

HDAC DEGRADER

-

Page/Page column 37; 71-72, (2021/07/31)

The disclosure provides compounds of formula (I). The compounds may be used to degrade the Histone Deacetylase (HDAC) family of enzymes, particularly HDAC1, 2 and 3 that exist in corepressor complexes. Accordingly, the compounds may

PROTAC-mediated degradation of class i histone deacetylase enzymes in corepressor complexes

Adams, Grace E.,Cowley, Shaun Michael,Hodgkinson, James T.,Millard, Christopher J.,Norris, James K. S.,Schwabe, John W. R.,Smalley, Joshua P.,Song, Yun

supporting information, p. 4476 - 4479 (2020/05/13)

We have identified a proteolysis targeting chimera (PROTAC) of class I HDACs 1, 2 and 3. The most active degrader consists of a benzamide HDAC inhibitor, an alkyl linker, and the von Hippel-Lindau E3 ligand. Our PROTAC increased histone acetylation levels and compromised colon cancer HCT116 cell viability, establishing a degradation strategy as an alternative to class I HDAC inhibition.

BIVALENT TARGETED CONJUGATES

-

Page/Page column 71; 72, (2020/05/28)

The invention provides conjugates that comprise a bivalent targeting moiety, a nucleic acid, and optional linking groups as well as synthetic intermediates and synthetic methods useful for preparing the conjugates, compositions comprising the bidentate targeting ligands and the conjugates, as well as methods for targeting therapeutic nucleic acids with the bidentate conjugates. The conjugates are useful to target therapeutic nucleic acids.

THERAPEUTIC METHODS

-

Page/Page column 204; 243; 244-245, (2020/05/28)

The invention provides methods and compositions for delivering a nucleic acid to a cell or the cytosol of the target cell. The method includes contacting the cell with, 1) a membrane-destabilizing polymer; and 2) a nucleic acid conjugate. The nucleic acid conjugate includes a targeting ligand bound to an optional linker and a nucleic acid.

IRAK DEGRADERS AND USES THEREOF

-

Paragraph 1986; 1987, (2019/07/10)

The present invention provides compounds, compositions thereof, and methods of using the same.

COMPOUNDS AND METHODS FOR OPTICAL SENSING OF ELECTRICAL ACTIVITY IN BIOLOGICAL SYSTEMS

-

Paragraph 0095, (2019/08/20)

Disclosed are tethered chromophore compositions comprising a membrane-spanning tether. The compounds can include covalently tethered fluorophore-quencher combinations useful for measuring action potentials and other fast electrical events in cells and tissues.

Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane

Hickey, Shane M.,Ashton, Trent D.,Boer, Gareth,Bader, Christie A.,Thomas, Michael,Elliott, Alysha G.,Schmuck, Carsten,Yu, Heidi Y.,Li, Jian,Nation, Roger L.,Cooper, Matthew A.,Plush, Sally E.,Brooks, Douglas A.,Pfeffer, Frederick M.

supporting information, p. 9 - 22 (2018/10/20)

The design, synthesis and evaluation of a small series of potent amphiphilic norbornane antibacterial agents has been performed (compound 10 MIC = 0.25 μg/mL against MRSA). Molecular modelling indicates rapid aggregation of this class of antibacterial agent prior to membrane association and insertion. Two fluorescent analogues (compound 29 with 4-amino-naphthalimide and 34 with 4-nitrobenz-2-oxa-1,3-diazole fluorophores) with good activity (MIC = 0.5 μg/mL against MRSA) were also constructed and confocal microscopy studies indicate that the primary site of interaction for this family of compounds is the bacterial membrane.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 18934-81-1